Probing the Mechanism of Action of Cry41Aa on HepG2 through the Establishment of a Resistant Subline

Cry41Aa, also called parasporin-3, belongs to a group of toxins from the entomopathogenic bacterium <i>Bacillus thuringiensis</i> that show activity against human cancer cells. Cry41Aa exhibits preferential cytocidal activity towards HL-60 (human promyelocytic leukaemia cells) and HepG2...

Full description

Bibliographic Details
Main Authors: Wided Souissi, Tweedie Alistair, Barbara Domanska, Eva Fortea, Michelle J. West, Jean-Louis Schwartz, Neil Crickmore
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Toxins
Subjects:
Online Access:https://www.mdpi.com/2072-6651/14/5/319
_version_ 1797494929995333632
author Wided Souissi
Tweedie Alistair
Barbara Domanska
Eva Fortea
Michelle J. West
Jean-Louis Schwartz
Neil Crickmore
author_facet Wided Souissi
Tweedie Alistair
Barbara Domanska
Eva Fortea
Michelle J. West
Jean-Louis Schwartz
Neil Crickmore
author_sort Wided Souissi
collection DOAJ
description Cry41Aa, also called parasporin-3, belongs to a group of toxins from the entomopathogenic bacterium <i>Bacillus thuringiensis</i> that show activity against human cancer cells. Cry41Aa exhibits preferential cytocidal activity towards HL-60 (human promyelocytic leukaemia cells) and HepG2 (human liver cancer cells) cell lines after being proteolytically activated. To better understand the mechanism of action of Cry41Aa, we evolved resistance in HepG2 cells through repeated exposure to increasing doses of the toxin. Concentrations of Cry41Aa that killed over 50% of the parental HepG2 cells had no significant effect on the viability of the resistant cells and did not induce either pore formation or p38 phosphorylation (both characteristic features of pore-forming toxins). Preliminary RNA sequencing data identified AQP9 as a potential mediator of resistance, but extensive investigations failed to show a causal link and did not support an enhanced cell repair process as the resistance mechanism.
first_indexed 2024-03-10T01:41:18Z
format Article
id doaj.art-5f9f4924240f4dfbb286378236fce861
institution Directory Open Access Journal
issn 2072-6651
language English
last_indexed 2024-03-10T01:41:18Z
publishDate 2022-04-01
publisher MDPI AG
record_format Article
series Toxins
spelling doaj.art-5f9f4924240f4dfbb286378236fce8612023-11-23T13:22:49ZengMDPI AGToxins2072-66512022-04-0114531910.3390/toxins14050319Probing the Mechanism of Action of Cry41Aa on HepG2 through the Establishment of a Resistant SublineWided Souissi0Tweedie Alistair1Barbara Domanska2Eva Fortea3Michelle J. West4Jean-Louis Schwartz5Neil Crickmore6School of Life Sciences, University of Sussex, Brighton BN1 9QG, UKSchool of Life Sciences, University of Sussex, Brighton BN1 9QG, UKSchool of Life Sciences, University of Sussex, Brighton BN1 9QG, UKDepartement of Pharmacology et Physiology, University of Montreal, Montreal, QC H3C 3J7, CanadaSchool of Life Sciences, University of Sussex, Brighton BN1 9QG, UKDepartement of Pharmacology et Physiology, University of Montreal, Montreal, QC H3C 3J7, CanadaSchool of Life Sciences, University of Sussex, Brighton BN1 9QG, UKCry41Aa, also called parasporin-3, belongs to a group of toxins from the entomopathogenic bacterium <i>Bacillus thuringiensis</i> that show activity against human cancer cells. Cry41Aa exhibits preferential cytocidal activity towards HL-60 (human promyelocytic leukaemia cells) and HepG2 (human liver cancer cells) cell lines after being proteolytically activated. To better understand the mechanism of action of Cry41Aa, we evolved resistance in HepG2 cells through repeated exposure to increasing doses of the toxin. Concentrations of Cry41Aa that killed over 50% of the parental HepG2 cells had no significant effect on the viability of the resistant cells and did not induce either pore formation or p38 phosphorylation (both characteristic features of pore-forming toxins). Preliminary RNA sequencing data identified AQP9 as a potential mediator of resistance, but extensive investigations failed to show a causal link and did not support an enhanced cell repair process as the resistance mechanism.https://www.mdpi.com/2072-6651/14/5/319cry toxinparasporinHepG2AQP9
spellingShingle Wided Souissi
Tweedie Alistair
Barbara Domanska
Eva Fortea
Michelle J. West
Jean-Louis Schwartz
Neil Crickmore
Probing the Mechanism of Action of Cry41Aa on HepG2 through the Establishment of a Resistant Subline
Toxins
cry toxin
parasporin
HepG2
AQP9
title Probing the Mechanism of Action of Cry41Aa on HepG2 through the Establishment of a Resistant Subline
title_full Probing the Mechanism of Action of Cry41Aa on HepG2 through the Establishment of a Resistant Subline
title_fullStr Probing the Mechanism of Action of Cry41Aa on HepG2 through the Establishment of a Resistant Subline
title_full_unstemmed Probing the Mechanism of Action of Cry41Aa on HepG2 through the Establishment of a Resistant Subline
title_short Probing the Mechanism of Action of Cry41Aa on HepG2 through the Establishment of a Resistant Subline
title_sort probing the mechanism of action of cry41aa on hepg2 through the establishment of a resistant subline
topic cry toxin
parasporin
HepG2
AQP9
url https://www.mdpi.com/2072-6651/14/5/319
work_keys_str_mv AT widedsouissi probingthemechanismofactionofcry41aaonhepg2throughtheestablishmentofaresistantsubline
AT tweediealistair probingthemechanismofactionofcry41aaonhepg2throughtheestablishmentofaresistantsubline
AT barbaradomanska probingthemechanismofactionofcry41aaonhepg2throughtheestablishmentofaresistantsubline
AT evafortea probingthemechanismofactionofcry41aaonhepg2throughtheestablishmentofaresistantsubline
AT michellejwest probingthemechanismofactionofcry41aaonhepg2throughtheestablishmentofaresistantsubline
AT jeanlouisschwartz probingthemechanismofactionofcry41aaonhepg2throughtheestablishmentofaresistantsubline
AT neilcrickmore probingthemechanismofactionofcry41aaonhepg2throughtheestablishmentofaresistantsubline